38685761|t|Anti-viral Effects of Pavetta indica Methanolic Extract and Acyclovir on Behavioral and Biochemical Parameters in Streptozotocin-induced Alzheimer's Disease in Rats.
38685761|a|BACKGROUND: Alzheimer's disease is a neurological dysfunction of the brain caused by neurodegeneration and oxidative stress. Some viruses, such as herpes viruses, HSV-1, and HSV-2, are causative agents of Alzheimer's disease and result in beta-amyloid peptide and tau protein accumulation in the brain. Some antiviral drugs, such as valacyclovir, acyclovir, and foscarnet, reduce amyloid-beta and P-tau. Pavetta indica leaves are also reported for their antiviral properties. The current study aimed to find out the significance of using Pavetta indica methanolic extract and acyclovir against Alzheimer's disease induced by streptozotocin. METHODS: Wistar rats received acyclovir and Pavetta indica methanolic extract orally at different dose ranges (50, 150, 450 mg/kg) and (125, 250, 500 mg/kg), respectively. The standard therapy, Rivastigmine (2 mg/kg), was given orally. RESULTS: Intracerebroventricular-streptozotocin produced significant alternations in behavioral assessments, including locomotor activity test, Morris water maze test, and elevated plus maze test. Moreover, intracerebroventricular-streptozotocin ameliorated the antioxidant defense activity by decreasing levels of catalase, superoxide dismutase, and reduced glutathione while enhancing the oxidative stress markers, including malondialdehyde, and total nitrite levels. Finally, the main findings showed that intracerebroventricular-streptozotocin significantly increased the inflammatory marker, tumor necrosis factor-alpha, and disturbed neurotransmitter mediators, including levels of acetylcholinesterase, glutamate, and gamma-amino butyric acid. CONCLUSION: In a dose-dependent manner, acyclovir and Pavetta indica methanolic extract treatments abrogated the streptozotocin-induced behavioral and neurological abnormalities in rats. The potential therapeutic effects of PIME and acyclovir administration in intracerebroventricular-streptozotocin-treated rats may be attributed to its potential antiviral, antioxidant, and anti-inflammatory effects. The current study suggests that Pavetta indica methanolic extract and acyclovir are promising therapeutic targets against Alzheimer's disease.
38685761	22	55	Pavetta indica Methanolic Extract	Chemical	-
38685761	60	69	Acyclovir	Chemical	MESH:D000212
38685761	114	128	Streptozotocin	Chemical	MESH:D013311
38685761	137	156	Alzheimer's Disease	Disease	MESH:D000544
38685761	160	164	Rats	Species	10116
38685761	178	197	Alzheimer's disease	Disease	MESH:D000544
38685761	203	240	neurological dysfunction of the brain	Disease	MESH:D001927
38685761	251	268	neurodegeneration	Disease	MESH:D019636
38685761	329	334	HSV-1	Species	10298
38685761	340	345	HSV-2	Species	10310
38685761	371	390	Alzheimer's disease	Disease	MESH:D000544
38685761	499	511	valacyclovir	Chemical	MESH:D000077483
38685761	513	522	acyclovir	Chemical	MESH:D000212
38685761	528	537	foscarnet	Chemical	MESH:D017245
38685761	563	568	P-tau	Gene	29477
38685761	570	584	Pavetta indica	Species	1008962
38685761	704	737	Pavetta indica methanolic extract	Chemical	-
38685761	742	751	acyclovir	Chemical	MESH:D000212
38685761	760	779	Alzheimer's disease	Disease	MESH:D000544
38685761	791	805	streptozotocin	Chemical	MESH:D013311
38685761	823	827	rats	Species	10116
38685761	837	846	acyclovir	Chemical	MESH:D000212
38685761	851	884	Pavetta indica methanolic extract	Chemical	-
38685761	1001	1013	Rivastigmine	Chemical	MESH:D000068836
38685761	1076	1090	streptozotocin	Chemical	MESH:D013311
38685761	1274	1288	streptozotocin	Chemical	MESH:D013311
38685761	1358	1366	catalase	Gene	24248
38685761	1402	1413	glutathione	Chemical	MESH:D005978
38685761	1470	1485	malondialdehyde	Chemical	MESH:D008315
38685761	1497	1504	nitrite	Chemical	MESH:D009573
38685761	1576	1590	streptozotocin	Chemical	MESH:D013311
38685761	1619	1631	inflammatory	Disease	MESH:D007249
38685761	1640	1667	tumor necrosis factor-alpha	Gene	24835
38685761	1731	1751	acetylcholinesterase	Gene	83817
38685761	1753	1762	glutamate	Chemical	MESH:D018698
38685761	1768	1792	gamma-amino butyric acid	Chemical	MESH:D005680
38685761	1834	1843	acyclovir	Chemical	MESH:D000212
38685761	1848	1881	Pavetta indica methanolic extract	Chemical	-
38685761	1907	1921	streptozotocin	Chemical	MESH:D013311
38685761	1945	1971	neurological abnormalities	Disease	MESH:D009461
38685761	1975	1979	rats	Species	10116
38685761	2018	2022	PIME	Chemical	-
38685761	2027	2036	acyclovir	Chemical	MESH:D000212
38685761	2079	2093	streptozotocin	Chemical	MESH:D013311
38685761	2102	2106	rats	Species	10116
38685761	2175	2187	inflammatory	Disease	MESH:D007249
38685761	2267	2276	acyclovir	Chemical	MESH:D000212
38685761	2319	2338	Alzheimer's disease	Disease	MESH:D000544
38685761	Negative_Correlation	MESH:D000212	29477
38685761	Negative_Correlation	MESH:D013311	24248
38685761	Positive_Correlation	MESH:D013311	MESH:D018698
38685761	Positive_Correlation	MESH:D013311	MESH:D009461
38685761	Positive_Correlation	MESH:D013311	MESH:D007249
38685761	Negative_Correlation	MESH:D017245	29477
38685761	Positive_Correlation	MESH:D013311	24835
38685761	Association	MESH:D013311	83817
38685761	Negative_Correlation	MESH:D005978	MESH:D013311
38685761	Negative_Correlation	MESH:D000212	MESH:D007249
38685761	Negative_Correlation	MESH:D000212	MESH:D000544
38685761	Negative_Correlation	MESH:D000212	MESH:D013311
38685761	Association	MESH:D009573	MESH:D013311
38685761	Negative_Correlation	MESH:D000212	MESH:D009461
38685761	Negative_Correlation	MESH:D000077483	29477
38685761	Positive_Correlation	MESH:D013311	MESH:D000544
38685761	Association	MESH:D005680	MESH:D013311
38685761	Positive_Correlation	MESH:D008315	MESH:D013311

